SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?


To: squetch who wrote (4628)4/16/1998 9:15:00 PM
From: Harold Engstrom  Read Replies (1) | Respond to of 9719
 
Saw those EPO press releases today - one from Transkaryotic and one from Amgen. The former release read like the headline, but the latter told a different story from what the headline reads. Amgen lost this round, but there is no indication that the court believes either side's case is stronger. Does anyone know if EPO is EPO or whether a different manufacturing process should entitle Transkaryotic to compete with Amgen on an equal footing?